Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
University of Pennsylvania Inc
Search grants from University of Pennsylvania Inc
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Serotonergic Dysfunction & Treatment in Adolescents with Major Depression
Pog 9470 - Phase I Trial of Ci 980 in Children with Solid Tumors
Minorities - Children;Psychiatric Nursing
Comparative Vertebrate Amelogenesis
Diabetes Mellitus and Disorders of Metabolism
Recently added grants:
Symposium on Cognitive Auditory Neuroscience (SCAN)
Amygdala Mediated Mechanisms Regulating Visceral Pain
The Roles of Complement Activation vs. Shiga Toxin Binding to Endothelium in eHUS.
Regulation of Niche Cell Differentiation to Sustain Intestinal Stem Cell Regeneration Against Gut Inflammation
Chromosomal death due to misincorporation of wrong material into DNA
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025118-000
Application #
6688659
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania Inc
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania Inc
NIH 2002
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania Inc
Comments
Be the first to comment on this grant